Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry.

ABSTRACT: The COVID-19 pandemic has caused a global public health crisis. There is a pressing need for evidence-based interventions to address the devastating clinical and public health effects of the COVID-19 pandemic. The Chinese scientists supported by private and government resources have adopted extensive efforts to identify effective drugs against the virus. To date, a large number of clinical trials addressing various aspects of COVID19 have been registered in the Chinese Clinical Trial Registry (ChiCTR), including more than 200 interventional studies. Under such an urgent circumstance, the scope and quality of these clinical studies vary significantly. Hence, this review aims to make a comprehensive analysis on the profiles of COVID-19 clinical trials registered in the ChiCTR, including a wi

SUBMITTER: Xu P 

PROVIDER: S-EPMC7473047 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature